EP Patent

EP0502092A1 — ORAL COMPOSITION FOR THE TREATMENT OF INTESTINAL FLAMMABLE DISEASES.

Assigned to Draco AB · Expires 1992-09-09 · 34y expired

What this patent protects

Oral pharmaceutical preparation for use in the treatment of inflammatory bowel disease, and use of certain glucocorticosteroids in the preparation of pharmaceutical preparations for the oral treatment of ulcerative colitis and certain aspects of Crohn's disease.

USPTO Abstract

Oral pharmaceutical preparation for use in the treatment of inflammatory bowel disease, and use of certain glucocorticosteroids in the preparation of pharmaceutical preparations for the oral treatment of ulcerative colitis and certain aspects of Crohn's disease.

Drugs covered by this patent

Patent Metadata

Patent number
EP0502092A1
Jurisdiction
EP
Classification
—
Expires
1992-09-09
Drug substance claim
No
Drug product claim
No
Assignee
Draco AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.